CLINICAL_TRIALS
trial_result
· 2024-11-18
Clinical Trial Update: A Study of IBI302 in Patients With nAMD [Phase 2]
Summary
A Phase 2 clinical trial evaluating IBI302 for neovascular age-related macular degeneration has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Neovascular Age-related Macular Degeneration | Phase 2 | Status: COMPLETED